New Horizon Health Limited (6606.HK)

14,140 -3,480 (-19,75%) Börsenschluss: 04:08PM HKT

New Horizon Health Limited

T1 Building
13th Floor 400 Jianger Road Binjiang District
Hangzhou 310052
China
86 57 1811 07210
https://ir.newhorizonbio.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 1.041

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Yeqing Zhu	CEO, Executive Chairman & Co-founder	10,87M	N/A	1972
Dr. Yiyou Chen Ph.D.	Executive Director & Chief Scientific Officer	5,59M	N/A	1972
Mr. Yu Gao	CFO & Joint Company Secretary	N/A	N/A	1983
Dr. Ning Lu	Chief Technology Officer	N/A	N/A	1971
Ms. Ming-Wai Mok	Joint Company Secretary	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in HKD.

Beschreibung

New Horizon Health Limited, an investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People's Republic of China. Its products include ColoClear, an early screening products for colon cancer; Pupu Tube, a fecal occult blood self test product; and UU Tube, a helicobacter pylori self-test products. The company is also involved in the research and development of medical diagnostic technology; provision of technical services, transfers, and consultation; and medical services, as well as financing services; manufacturing and sales of medical and laboratory equipment, and fecal occult blood test kits; and technological import and export activities. The company was founded in 2015 and is headquartered in Hangzhou, China.

Corporate Governance

New Horizon Health Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.